In our study, treatment with ER1626, ERβ protein was raised in MCF-7 and Ishikawa cells, which suggested the mechanism of anti breast cancer and endometrial cancer of ER1626 was associated with the increment of ERβ protein. This evidence concerns the gene ESR2 and endometrial cancer.